The behavior intervention on control of glucose among diabetic patients
Phase 1
- Conditions
- Diabetes.Endocrine, nutritional and metabolic diseases (E00-E90): Diabetes mellitusE10-E14
- Registration Number
- IRCT20111119008132N7
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Having a registry profile in diabetes clinic of Khoy
Having consent to participant in the study.
Exclusion Criteria
Having cognitive disorders
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HBA1C. Timepoint: before intervention and after 24 weeks. Method of measurement: HbA1c Test.
- Secondary Outcome Measures
Name Time Method Adherence to medical care. Timepoint: 2 and 6 month after intervention. Method of measurement: The adherence questionnaire for diabetic patients.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie behavioral interventions in diabetes glucose control?
How effective is the multi-dimensional behavioral intervention compared to standard diabetes care in reducing HbA1C?
Which biomarkers correlate with successful glucose control in behavioral diabetes interventions?
What adverse events are associated with multi-dimensional behavioral interventions in type 2 diabetes patients?
Are there combination therapies that enhance behavioral interventions for diabetes mellitus E10-E14?